<p>Filled bars, placebo-controlled study; open bars, active comparator study; FEV1(L), mean change from baseline ± standard deviation.</p
Each plot shows data for one participant and the data are the mean SD of the step frequency (SF) cha...
<p>A–F represents the change from baseline in TB ELISPOT vs placebo by treatment in HIV-positive (A,...
<p>Transverse line is the mean and whiskers are maximum and minimum. There was a decline in mean %FE...
<p>Blue dashed line = placebo-treated patients. Black solid line = itraconazole-treated patients. 95...
<p>Mean change of HbA1c from baseline (a. saxagliptin vs placebo; b. saxagliptin vs active comparato...
<p>A, B represents the change from baseline in the WHO test vs placebo by treatment and HIV-status. ...
Each plot shows data for one participant, and the data are the mean SD of the step frequency (SF) ch...
<p>NMF, nalmefene; PBO, placebo; SF-36 MCS, Short-Form health survey-36 mental component summary. * ...
Mean (95% confidence interval) percentage change in inter-beat intervals from baseline, across parti...
<p>Data are means ± standard deviation</p><p>Baseline parameters before aspartame and placebo prepar...
<p>NMF, nalmefene; PBO, placebo; SF-36 PCS, Short-Form health survey-36 physical component summary. ...
<p>Within group change from Week 0: * p≤0.05, Ω small effect (Effect size> 0.2).</p><p>Between group...
<p>Mean difference (MD) of FEV1 in % predicted between study participants exposed to bg dust at the ...
<p>Change in placebo was calculated as difference between pain scores in the placebo arm (pre-minus ...
In most clinical trials comparing a test drug and a control (e.g., a placebo control or an active co...
Each plot shows data for one participant and the data are the mean SD of the step frequency (SF) cha...
<p>A–F represents the change from baseline in TB ELISPOT vs placebo by treatment in HIV-positive (A,...
<p>Transverse line is the mean and whiskers are maximum and minimum. There was a decline in mean %FE...
<p>Blue dashed line = placebo-treated patients. Black solid line = itraconazole-treated patients. 95...
<p>Mean change of HbA1c from baseline (a. saxagliptin vs placebo; b. saxagliptin vs active comparato...
<p>A, B represents the change from baseline in the WHO test vs placebo by treatment and HIV-status. ...
Each plot shows data for one participant, and the data are the mean SD of the step frequency (SF) ch...
<p>NMF, nalmefene; PBO, placebo; SF-36 MCS, Short-Form health survey-36 mental component summary. * ...
Mean (95% confidence interval) percentage change in inter-beat intervals from baseline, across parti...
<p>Data are means ± standard deviation</p><p>Baseline parameters before aspartame and placebo prepar...
<p>NMF, nalmefene; PBO, placebo; SF-36 PCS, Short-Form health survey-36 physical component summary. ...
<p>Within group change from Week 0: * p≤0.05, Ω small effect (Effect size> 0.2).</p><p>Between group...
<p>Mean difference (MD) of FEV1 in % predicted between study participants exposed to bg dust at the ...
<p>Change in placebo was calculated as difference between pain scores in the placebo arm (pre-minus ...
In most clinical trials comparing a test drug and a control (e.g., a placebo control or an active co...
Each plot shows data for one participant and the data are the mean SD of the step frequency (SF) cha...
<p>A–F represents the change from baseline in TB ELISPOT vs placebo by treatment in HIV-positive (A,...
<p>Transverse line is the mean and whiskers are maximum and minimum. There was a decline in mean %FE...
DOI
Add to ORKG